In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3beta
- PMID: 8764598
- DOI: 10.1046/j.1471-4159.1996.67020699.x
In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3beta
Abstract
The two pathological lesions found in the brains of Alzheimer's disease patients, neurofibrillary tangles and neuritic plaques, are likely to be formed through a common pathway. Neurofibrillary tangles are intracellular aggregates of paired helical filaments, the main component of which is hyperphosphorylated forms of the microtubule-associated protein tau. Extracellular neuritic plaques and diffuse and vascular amyloid deposits are aggregates of beta-amyloid protein, a 4-kDa protein derived from the amyloid precursor protein (APP). Using conditions in vitro under which two proline-directed protein kinases, glycogen synthase kinase-3beta (GSK-3beta) and mitogen-activated protein kinase (MAPK), were able to hyperphosphorylate tau, GSK-3beta but not MAPK phosphorylated recombinant APPcyt. The sole site of phosphorylation in APPcyt by GSK-3beta was determined by phosphoamino acid analysis and phosphorylation of APPcyt mutant peptides to be Thr743 (numbering as for APP770). This site was confirmed by endoproteinase Glu-C digestion of APPcyt and peptide sequencing. The ability of GSK-3beta to phosphorylate APPcyt and tau provides a putative link between the two lesions and indicates a critical role of GSK-3beta in the pathogenesis of Alzheimer's disease.
Similar articles
-
Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.Neurosci Res. 1998 Aug;31(4):317-23. doi: 10.1016/s0168-0102(98)00061-3. Neurosci Res. 1998. PMID: 9809590
-
Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.Curr Biol. 1994 Dec 1;4(12):1077-86. doi: 10.1016/s0960-9822(00)00246-3. Curr Biol. 1994. PMID: 7704571
-
Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase.J Neurosci. 2001 Jul 15;21(14):4987-95. doi: 10.1523/JNEUROSCI.21-14-04987.2001. J Neurosci. 2001. PMID: 11438574 Free PMC article.
-
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.J Biochem. 1997 Feb;121(2):179-88. J Biochem. 1997. PMID: 9089387 Review.
-
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.Behav Brain Res. 2018 Feb 26;339:57-65. doi: 10.1016/j.bbr.2017.11.015. Epub 2017 Nov 21. Behav Brain Res. 2018. PMID: 29158110 Review.
Cited by
-
GSK-3: Functional Insights from Cell Biology and Animal Models.Front Mol Neurosci. 2011 Nov 16;4:40. doi: 10.3389/fnmol.2011.00040. eCollection 2011. Front Mol Neurosci. 2011. PMID: 22110425 Free PMC article.
-
Fasciclin II signals new synapse formation through amyloid precursor protein and the scaffolding protein dX11/Mint.J Neurosci. 2005 Jun 22;25(25):5943-55. doi: 10.1523/JNEUROSCI.1144-05.2005. J Neurosci. 2005. PMID: 15976083 Free PMC article.
-
The role of glycoproteins in neural development function, and disease.Mol Neurobiol. 1998 Apr;16(2):163-220. doi: 10.1007/BF02740643. Mol Neurobiol. 1998. PMID: 9588627 Review.
-
Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.eNeuro. 2017 Mar 27;4(2):ENEURO.0149-16.2017. doi: 10.1523/ENEURO.0149-16.2017. eCollection 2017 Mar-Apr. eNeuro. 2017. PMID: 28374012 Free PMC article.
-
Phosphorylation Signaling in APP Processing in Alzheimer's Disease.Int J Mol Sci. 2019 Dec 27;21(1):209. doi: 10.3390/ijms21010209. Int J Mol Sci. 2019. PMID: 31892243 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases